This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
S Arunabh , S Pollack , J Yeh & JF Aloia (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. Journal of Clinical Endocrinology and Metabolism 88, 157–161.
JL Barzilay , L Abraham , SR Heckbert , M Cushman , LH Kuller , HE Resnick & RP Tracy (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50, 2384–2389.
BN Becker , DA Hullet , JK O'Herrin , G Malin , HW Sollinger & H DeLuca (2002) Vitamin D as immunomodulatory therapy for kidney transplantation. Transplantation 74, 1204–1206.
EA Bermudez , N Rifai , J Buring , JA Manson & PM Ridker (2002) Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arteriosclerosis, Thrombosis and Vascular Biology 22, 1668–1673.
B Beutler , J Mahoney , N Le Trang , P Pekala & A Cerami (1985) Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264. Journal of Experimental Medicine 161, 984–995.
UN Das (2001) Is obesity an inflammatory condition? Nutrition 17, 953–966.
HF DeLuca & C Zierold (1998) Mechanisms and functions of vitamin D. Nutrition Reviews 56, S4–S10.
G Engström , L Stavenow , B Hedblad , P Lind , KF Eriksson , L Janzon & F Lindgarde (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality of myocardial infarction and stroke: a population-based study. Diabetes 52, 442–447.
JM Fernandez-Real , M Broch , J Vendrell & W Rieart (2000) Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. Journal of Clinical Endocrinology and Metabolism 85, 1334–1339.
ES Ford (2002) Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. American Journal of Epidemiology 155, 57–64.
DJ Freeman , J Norrie , MJ Caslake , A Gaw , I Ford , GD Lowe , DS O'Reilly , CJ Packard , N Sattar & West of Scotland Coronary Prevention Study (2002) C-reactive protein is an independent predictor of risk of the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51, 1596–1600.
H Gewurz , XH Zhang & TF Lint (1995) Structure and function of the pentraxins. Current Opinion in Immunology 7, 54–64.
TS Han , N Sattar , K Williams , C González-Villalpando , ME Lean & SM Haffner (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25, 2016–2021.
H Harant , D Spinner , GS Reddy & IJ Lindley (2000) Natural metabolites of 1-alpha, 25-dihydroxyvitamin D3 retain biologic activity mediated through the vitamin D receptor. Journal of Cellular Biochemistry 78, 112–120.
H Harant , B Wolff & IJ Lindley (1998) 1-Alpha, 25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Letters 436, 239–334.
RS Hundal , KF Petersen , AB Mayerson , PS Randhawa , S Inzucchi , SE Shoelson & GI Shulman (2002) Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. Journal of Clinical Investigation 109, 1321–1326.
C Jiang , AT Ting & B Seed (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82–86.
S Kadowaki & AW Norman (1985) Demonstration that the vitamin D metabolite 1,25(OH)2-D3 and not 24R,25(OH)2-D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 34, 315–320.
C Lagraine & Y Lebranchu (2003) Effects of immunosupressive drugs on dendritic cells and tolerance induction. Transplantation 75, 37S–42S.
JM Lemire (1995) Immunomodulatory actions of 1,25-dihydroxivitamin D3. Journal of Steroid Biochemistry and Molecular Biology 53, 599.
BD Mahon , A Wittke , V Weaver & MT Cantorna (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Journal of Cellular Biochemistry 89, 922–932.
J O'Kelly , J Hisatake , Y Hisatake , J Bishop , A Norman & HP Koeffler (2002) Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. Journal of Clinical Investigation 109, 1091–1099.
B-J Ogunkolade , B Boucher , JM Prahl , SA Bustin , JM Burrin , K Noonan , BV North , N Mannan , MF McDermott , HF DeLuca & GA Hitman (2002) Vitamin D receptor (VDR) mRNA and protein levels in relation to vitamin D status, insulin secretory capacity, andVDR genotype in Bangladeshi Asians. Diabetes 51, 2294–2300.
D Papanicolaou (2000) Editorial: Interleukin-6: the endocrine cytokine. Journal of Clinical Endocrinology and Metabolism 85, 1331–1333.
MB Pepys & GM Hirschfield (2003) C-reactive protein: a critical update. Journal of Clinical Investigation 111, 1805–1812.
J Pichler , M Gerstmayr , Z Szepfalusi , R Urbanek , M Peterlik & M Willheim (2002) 1α,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatric Research 52, 12–18.
JC Pickup (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes mellitus. Diabetes Care 27, 813–823.
A Pittas , NA Joseph , A Greenberg (2004) Adipocytokines and insulin resistance. Journal of Clinical Endocrinology and Metabolism 89, 447–452.
AD Pradhan , JE Manson , N Rifai , JE Buring & PM Ridker (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327–334.
GM Reaven (1988) Role of insulin resistance in human disease. Diabetes 37, 1595–1607.
MI Schmidt , BB Duncan , AR Sharrett , G Lindberg , PJ Savage , S Offenbacher , MI Azambuja , RP Tracy & G Heiss (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353, 1649–1652.
R Scragg , M Sowers & C Bell (2004) Serum 25-hydroxivitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27, 2813–2818.
JJ Senn , PJ Klover , IA Nowak & RA Mooney (2002) Interleukin-6 induces cellular insulin-resistance in hepatocytes. Diabetes 51, 3391–3399.
PM Timms , N Mannan , GA Hitman , K Noonan , PG Mills , D Syndercombe-Court , E Aganna , CP Price & BJ Boucher (2002) Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95, 787–796.
KJ Tracey & A Cerami (1990) Metabolic responses to cachectin/TNF: a brief review. Annals of the New York Academy of Sciences 587, 325–331.
B Vozarova , C Weyer , RS Lindsay , RE Pratley , C Bogardus & PA Tataranni (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51, 455–461.
H Xu , GT Barnes , Q Yang , G Tan , D Yang , CJ Chou , J Sole , A Nichols , JS Ross , LA Tartaglia & H Chen (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 112, 1821–1830.
M Yuan , N Kostantopoulos , J Lee , L Hansen , ZW Li , M Karin & SE Shoelson (2001) Reversal of obesity and diet-induced insulin resitance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673–1677.